Although immunological markers like anti-Saccharomyces cerevisiae antibodies or genetic variants of NOD2 are statistically associated with prognosis of surgical intervention in IBD [5], these markers often lack sensitivity or are not frequent enough to be clinically useful. Here, NOD2 is linked to inflammatory bowel disease.